Table 10.
Availability of surveyed high-end antibiotics at secondary care and tertiary care public facilities and at private sector facilities
| Antibiotic name | Public sector (n = 15) |
Retail pharmacies |
Chain pharmacies |
|---|---|---|---|
| (n = 40) | (n = 40) | ||
| Cefepime 1 g Inj |
20.0% |
0.0% |
10.0% |
| Ceftazidime 1 g vial |
73.3% |
5.0% |
20.0% |
| Colistin 1000000units/vial |
0.0% |
0.0% |
2.5% |
| Gemifloxacin 320 mg tab/cap |
0.0% |
37.5% |
50.0% |
| Imipenem + cilastin500mg + 500 mg Inj |
13.3% |
0.0% |
22.5% |
| Meropenem 500 mg Inj |
60.0% |
32.5% |
52.5% |
| Moxifloxacin 400 mg tab/cap |
0.0% |
40.0% |
72.5% |
| Vancomycin 500 mg inj | 53.3% | 5.0% | 7.5% |